FibroGen shares are trading lower after the company announced a 1-for-25 reverse stock split.

+0.70%

FibroGen, Inc.

FGEN

0.00

FibroGen shares are trading lower after the company announced a 1-for-25 reverse stock split.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Insiders Who Sold US$628k Of Tyra Biosciences Made The Right Call

Twist Bioscience (TWST) Is Up 6.3% After Higher Sales and Narrowed Losses in Q4 2025 Results – Has the Bull Case Changed?

NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 11:50 AM

Moderna Secures $1.5 Billion Credit Facility Led by Ares Capital

Arcutis Biotherapeutics (ARQT) Is Up 17.5% After FDA Review Accepted for Pediatric ZORYVE Expansion - Has The Bull Case Changed?

Sanofi and Regeneron win EU approval for Dupixent in chronic spontaneous urticaria

Pre-Bell Movers | IVP Picks up 41.7%; Here Are 20 Stocks Moving Premarket

Upstream Bio to Present at Major December Healthcare Investor Conferences